Craig Wong-Pan

Stock Analyst at RBC Capital

(1.08)
# 3,846
Out of 5,032 analysts
341
Total ratings
50.7%
Success rate
-1.3%
Average return

Stocks Rated by Craig Wong-Pan

Healius Limited
Sep 25, 2026
Upgraded: Hold
Price Target: $0.37 → $0.42
Current: $0.41
Upside: +3.19%
Telix Pharmaceuticals Limited
Sep 21, 2026
Upgraded: Buy
Price Target: $19.00 → $21.00
Current: $15.86
Upside: +32.41%
Australian Clinical Labs Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $2.40
Current: $2.81
Upside: -14.59%
Ansell Limited
Sep 15, 2026
Downgraded: Hold
Price Target: $36.00 → $38.00
Current: $45.54
Upside: -16.56%
Cochlear Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $117.00
Current: $130.57
Upside: -10.39%
CSL Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $148.00 → $213.00
Current: $180.32
Upside: +18.12%
Integral Diagnostics Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $3.20
Current: $2.12
Upside: +50.94%
Nanosonics Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $3.00 → $3.75
Current: $2.90
Upside: +29.53%
Regis Healthcare Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $5.00
Current: $4.34
Upside: +15.34%
Ramsay Health Care Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $52.00 → $68.00
Current: $54.87
Upside: +23.93%
Reiterated: Hold
Price Target: $21.00
Current: $18.77
Upside: +11.91%
Upgraded: Buy
Price Target: $39.00 → $52.00
Current: $47.00
Upside: +10.64%
Upgraded: Buy
Price Target: $244 → $262
Current: $220.69
Upside: +18.72%
Downgraded: Hold
Price Target: $82
Current: $116.75
Upside: -30.14%
Reiterated: Hold
Price Target: $0.75 → $0.72
Current: $0.75
Upside: -3.36%
Reiterated: Hold
Price Target: $0.12 → $0.13
Current: $0.10
Upside: +27.45%
Reiterated: Sell
Price Target: $16.04
Current: $22.24
Upside: n/a
Reiterated: Buy
Price Target: $31.60
Current: $12.12
Upside: n/a
Downgraded: Sell
Price Target: $6.57
Current: $21.07
Upside: n/a